Three memebers of the Hyperdrive team.

Globally, all pharmaceutical companies face the same challenge of finding effective drug targets that will translate into higher drug approval rates.

Hyperdrive technology increases the accuracy of, and cuts the time required for, drug candidate selection, reducing the costs of drug development.

The technology takes advantage of naturally occurring processes that allow genomic information from a cell to be translated into its corresponding protein library to be tested for new and emergent drug targets.

The rapid access to new target information of any drug candidate allows pharmaceutical companies to make more rational selections and unlock hidden value.

Lead Institute

Macquarie University

Team members

Peter Karuso
Fei Liu
Paul Jaschke
Kavita Ragini

Contact ON

Your contact details

First name must be filled in

We'll need to know what you want to contact us about so we can give you an answer.